Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 406-640-0 | CAS number: 136920-07-5 KEROFLUX ES 3241
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP and guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- A mixture of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide; 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide
- EC Number:
- 406-640-0
- EC Name:
- A mixture of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide; 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide
- Cas Number:
- 136920-07-5
- Molecular formula:
- C58H114N4O6 - C154H308N6O4
- IUPAC Name:
- Reaction mass of 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C12-C18)alkylacetamide and {[2-(Carboxymethyl-di(C12-C18)alkylcarbamoylmethyl-amino)-ethyl]-di(C12-C18)alkylcarbamoylmethyl-amino}-acetic acid
- Reference substance name:
- Keroflux ES 3241
- IUPAC Name:
- Keroflux ES 3241
- Details on test material:
- Batch No.: (T 75492/ST 1414/90) Partie 1
Manufacturing/Sampling Date: 10.10.1990
Appearance: Light beige, solid; liquid at 80°C
Storage: 4-6°C
Constituent 1
Constituent 2
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River GmbH, WIGA, Sulzfeld, D
- Weight at study initiation: ca. 29 g
- Housing: single in Makrolon cages, type I
- Assigned to test groups randomly: yes, under following basis: appropriate computer program
- Diet: Standardized pelleted feed (Kliba Haltungsdiaet, Klingentalmuehle AG, Kaiseraugst, CH; ad libitum
- Water: drinking water; ad libitum
- Acclimation period: ca. 1 week (housing 5 per cage (Makrolon cage, type M III))
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- olive oil
- Details on exposure:
- The dose leveis were set as follows: Due to technical reasons the highest applicable amount was 3000 mg/kg body weight at a temperature of not less than 42°C in order to guarantee that the test substance stayed liquid and did not become solid for administration. Higher doses were only possible at a temperature of > 60°C which could not be applicated any longer. Therefore, a dose of 3000 mg/kg body weight was selected as the highest dose in the present cytogenetic study. 1500 mg/kg and 750 mg/kg body weight were administered as further doses.
The substance to be administered per kg body weight was heaten up to 80°C and dissolved in olive oil. Test group 1 received 10 ml olive oil/kg body weight. Test group 2 were given 3000 mg test substance/kg body weight or 10 ml/kg body weight of a solution with a concentration of 30 g/100 ml. Test group 3 was given 1500 mg test substance/kg body weight or 10 ml/kg body weight of a solution with a concentration of 15 g/100 ml. Test group 4 was given 750 mg test substance/kg body weight or 10 ml/kg body weight of a solution with a concentration of 7.5 g/100 ml. - Duration of treatment / exposure:
- Sacrifice after 16, 24 or 48 hours
- Frequency of treatment:
- single administration
- Post exposure period:
- Sacrifice after 16, 24 or 48 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
3000 mg/kg, 1500 mg/kg, 750 mg/kg and 0 mg/kg body weight in a volume of 10 ml/kg body weight in each case
Basis:
actual ingested
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- As positive control for clastogenicity, 20 mg of cyclophosphamide/kg body weight, dissolved in aqua dest., was administered once orally to male and female animals in a volume of 10 ml/kg body weight.
As positive contral for spindle poison effects, 0.15 mg of vincristine/kg body weight, dissolved in aqua dest., was administered once intraperitoneally to male and female animals in a volume of 10 ml/kg body weight.
Examinations
- Tissues and cell types examined:
- bone marrow
- Details of tissue and slide preparation:
- The two femora were prepared from the animals, and all soft tissues were removed. After cutting off the epiphyses, the bone marrow was flushed out of the diaphysis into a centrifuge tube using a cannula filled with fetal calf serum which was at 37°C (about 2 ml/ femur). The suspension was mixed thoroughly with a pipette, centrifuged at 1500 rpm for 5 minutes, the supernatant was removed except for a few drops, and the precipitate was resuspended. One drop of this suspension was dropped onto clean microscopic slides, using a Pasteur pipette. Smears were prepared using slides with ground edges, the preparations were dried in the air and subsequently stained.
The slides were stained in eosin and methylene blue solution for 5 minutes, rinsed in aqua dest. and then placed in fresh aqua dest. for 2 or 3 minutes. They were finally stained in Giemsa solution for 12 minutes. After being rinsed twice in aqua dest. and clarified in xylene, the preparations were embedded in Corbit-Balsam. - Evaluation criteria:
- In general, 1000 polychromatic erythrocytes from each of the male and female animais of every test group are evaluated and investigated for micronuclei. The normochromatic erythrocytes, which occur, are also scored.
- Statistics:
- A statistical evaluation was not necessary to perform.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- The number of polychromatic micronucleated erythrocytes after test substance treatment was within the range of the actual control value and within the historical control values.
Any other information on results incl. tables
irregular respiration was observed in all treatment groups 15 -30 min after treatment.
Substance | Dose (mg/kg) | Sacrifice interval (h) | PCE with micronuclei (‰) | NCE with micronuclei (‰) | Ratio NCE/PCE |
olive oil | solvent | 24 | 1.7 | 1.54 | 0.45 |
test substance | 750 | 24 | 1.9 | 1.54 | 0.39 |
test substance | 1500 | 24 | 1.5 | 1.84 | 0.44 |
test substance | 3000 | 16 | 1.6 | 0.84 | 0.48 |
test substance | 3000 | 24 | 1.9 | 0.93 | 0.43 |
test substance | 3000 | 48 | 2.0 | 1.51 | 0.46 |
cyclophosphamide | 20 | 24 | 10.4 | 3.03 | 0.20 |
vincristine | 0.15 | 24 | 35.8 | 2.15 | 0.33 |
PCE = polychromatic erythrocyts (10,000 were scored for micronuclei) | |||||
NCE = normochromatic erythrocyts | |||||
The NCE/PCE ratio is based on the scoring of 10,000 erythrocyts |
According to the results of the present study, the single oral administration of Keroflux ES 3241 in doses of 3000 mg/kg, 1500 mg/kg and 750 mg/kg body weight did not lead to any increase in the number of polychromatic erythrocytes containing either small or large micronuclei. The rate of micronuclei was always in the same range as that of the negative control in all dose groups and at all sacrifice intervals. No inhibition of erythropoiesis determined from the ratio of polychromatic to normochromatic erythrocytes was detected.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.